Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)

Total Valuation

TPEX:6576 has a market cap or net worth of TWD 12.65 billion. The enterprise value is 12.04 billion.

Market Cap	12.65B
Enterprise Value	12.04B

Important Dates

The next estimated earnings date is Monday, November 10, 2025.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6576 has 154.86 million shares outstanding. The number of shares has increased by 7.70% in one year.

Current Share Class	154.86M
Shares Outstanding	154.86M
Shares Change (YoY)	+7.70%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	2.90%
Owned by Institutions (%)	1.17%
Float	126.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	28.58
PB Ratio	13.02
P/TBV Ratio	14.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.48
EV / Sales	27.18
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.12

Financial Position

The company has a current ratio of 2.92, with a Debt / Equity ratio of 0.26.

Current Ratio	2.92
Quick Ratio	2.22
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	-0.17
Interest Coverage	-247.73

Financial Efficiency

Return on equity (ROE) is -143.98% and return on invested capital (ROIC) is -71.26%.

Return on Equity (ROE)	-143.98%
Return on Assets (ROA)	-55.10%
Return on Invested Capital (ROIC)	-71.26%
Return on Capital Employed (ROCE)	-122.56%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.28
Inventory Turnover	1.34

Taxes

In the past 12 months, TPEX:6576 has paid 20.30 million in taxes.

Income Tax	20.30M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.02% in the last 52 weeks. The beta is 0.75, so TPEX:6576's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	+2.02%
50-Day Moving Average	76.53
200-Day Moving Average	74.23
Relative Strength Index (RSI)	55.76
Average Volume (20 Days)	459,563

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6576 had revenue of TWD 442.76 million and -1.42 billion in losses. Loss per share was -9.70.

Revenue	442.76M
Gross Profit	262.43M
Operating Income	-1.39B
Pretax Income	-1.40B
Net Income	-1.42B
EBITDA	-1.33B
EBIT	-1.39B
Loss Per Share	-9.70

Balance Sheet

The company has 867.25 million in cash and 250.77 million in debt, giving a net cash position of 616.48 million or 3.98 per share.

Cash & Cash Equivalents	867.25M
Total Debt	250.77M
Net Cash	616.48M
Net Cash Per Share	3.98
Equity (Book Value)	971.84M
Book Value Per Share	6.28
Working Capital	825.40M

Cash Flow

In the last 12 months, operating cash flow was -1.36 billion and capital expenditures -120.30 million, giving a free cash flow of -1.48 billion.

Operating Cash Flow	-1.36B
Capital Expenditures	-120.30M
Free Cash Flow	-1.48B
FCF Per Share	-9.57

Margins

Gross Margin	59.27%
Operating Margin	-314.50%
Pretax Margin	-316.06%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:6576 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.70%
Shareholder Yield	n/a
Earnings Yield	-11.22%
FCF Yield	-11.72%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6576 has an Altman Z-Score of 3.5 and a Piotroski F-Score of 4.

Altman Z-Score	3.5
Piotroski F-Score	4